Stock PZRXQ PHASERX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company PhaseRx, Inc.

Equities

PZRXQ

US71723F1030

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 10:42:58 2023-09-21 am EDT 		5-day change 1st Jan Change
0.0002 USD -.--% Intraday chart for PhaseRx, Inc. -.--% -.--%
2019 Roivant Sciences GmbH cancelled the acquisition of substantially all of the assets from PhaseRx, Inc. CI
2018 PhaseRx, Inc. Bankruptcy Case Dismissed CI

Business Summary

Pz Wind Down, Inc., formerly, PhaseRx, Inc. is a biopharmaceutical company developing a portfolio of mRNA products to correct life-threatening inherited liver diseases in children. The Company's initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of 12 and are characterized by the body's inability to remove ammonia from the blood. The Company's i-ERT approach is enabled by its Hybrid mRNA Technology platform and is applicable to a number of inherited liver diseases. The Company is headquartered in Seattle.

Number of employees: 10

Sales per Business

USD in Million2015Weight2016Weight Delta
Biopharmaceutical
nan %
0 100.0 % 0 nan % -100.00%

Sales per region

USD in Million2015Weight2016Weight Delta
United Stated
nan %
0 100.0 % 0 nan % -100.00%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,690,329 11,690,329 ( 100.00 %) 0 100.00 %

Company contact information

PhaseRx, Inc.

410 West Harrison Street Suite 300

98119, Seattle

+206 805 6300

address PhaseRx, Inc.(PZRXQ)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
PHASERX, INC. Stock PhaseRx, Inc.
-.--% 2.34K
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-1.17% 104B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+2.87% 97.47B
ARGENX SE Stock argenx SE
+2.13% 22.25B
BIONTECH SE Stock BioNTech SE
-14.77% 21.68B
GENMAB A/S Stock Genmab A/S
-8.79% 18.2B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-39.98% 17.02B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.21% 16.36B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+8.55% 14.39B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+35.75% 12.37B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. PZRXQ Stock
  4. Company PhaseRx, Inc.